These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33274062)

  • 1. Nigeria's public health response to the COVID-19 pandemic: January to May 2020.
    Dan-Nwafor C; Ochu CL; Elimian K; Oladejo J; Ilori E; Umeokonkwo C; Steinhardt L; Igumbor E; Wagai J; Okwor T; Aderinola O; Mba N; Hassan A; Dalhat M; Jinadu K; Badaru S; Arinze C; Jafiya A; Disu Y; Saleh F; Abubakar A; Obiekea C; Yinka-Ogunleye A; Naidoo D; Namara G; Muhammad S; Ipadeola O; Ofoegbunam C; Ogunbode O; Akatobi C; Alagi M; Yashe R; Crawford E; Okunromade O; Aniaku E; Mba S; Agogo E; Olugbile M; Eneh C; Ahumibe A; Nwachukwu W; Ibekwe P; Adejoro OO; Ukponu W; Olayinka A; Okudo I; Aruna O; Yusuf F; Alex-Okoh M; Fawole T; Alaka A; Muntari H; Yennan S; Atteh R; Balogun M; Waziri N; Ogunniyi A; Ebhodaghe B; Lokossou V; Abudulaziz M; Adebiyi B; Abayomi A; Abudus-Salam I; Omilabu S; Lawal L; Kawu M; Muhammad B; Tsanyawa A; Soyinka F; Coker T; Alabi O; Joannis T; Dalhatu I; Swaminathan M; Salako B; Abubakar I; Fiona B; Nguku P; Aliyu SH; Ihekweazu C
    J Glob Health; 2020 Dec; 10(2):020399. PubMed ID: 33274062
    [No Abstract]   [Full Text] [Related]  

  • 2. Adapting public health response through lessons learnt: Nigeria's experience from Lassa fever and COVID-19.
    Saleh F; Popoola BO; Arinze C; Elisha AA; Dan-Nwafor C; Olajide L; Ilori E; Ochu CL; Ihekweazu CA
    BMJ Glob Health; 2022 Sep; 7(Suppl 7):. PubMed ID: 36130796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deadly Lassa-fever outbreak tests Nigeria's revamped health agency.
    Maxmen A
    Nature; 2018 Mar; 555(7697):421-422. PubMed ID: 29565399
    [No Abstract]   [Full Text] [Related]  

  • 4. A call to action for translational sciences in COVID-19 and future pandemics.
    Wan KK; Davis D; Lee TN; Ford-Scheimer SL; Andreu AL; Bietrix F; Bryans J; Castro MT; Chiba N; Faupel-Badger JM; Haynes B; Hirasawa R; Morel CM; Souza TML; Morrow D; Munro T; Newman S; Ussi AE; Zorzal PB; Hall MD; Lo DC; Cutillo CM
    Nat Rev Drug Discov; 2022 Mar; 21(3):165-166. PubMed ID: 35091700
    [No Abstract]   [Full Text] [Related]  

  • 5. [The pandemic caused by SARS-CoV-2: more than a serious health crisis, a change of time and lessons to be learned urgently].
    Bréchot C
    Med Sci (Paris); 2020 Dec; 36(12):1107-1108. PubMed ID: 33200980
    [No Abstract]   [Full Text] [Related]  

  • 6. Responding to a Pandemic Through Social and Behavior Change Communication: Nigeria's Experience.
    Ochu CL; Akande OW; Ihekweazu V; Kaduru C; Akomolafe O; Egwuenu A; Anueyiagu C; Agenyi J; Ejibe U; Falola-Anoemuah Y; Umar-Farouk O; Oyebanji O; Fagbemi B; Oguanuo C; Ojumu T; Saad H; Mohammed T; Disu Y; Ihekweazu C
    Health Secur; 2021; 19(2):223-228. PubMed ID: 33346721
    [No Abstract]   [Full Text] [Related]  

  • 7. The World after COVID-19: Reflections on Global Health and Policy.
    Yassin N; Saleh S
    Ann Glob Health; 2021; 87(1):72. PubMed ID: 34327119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus disease 2019 and pregnancy is déjà vu all over again.
    Rasmussen SA; Jamieson DJ
    BJOG; 2022 Jan; 129(2):188-191. PubMed ID: 34379870
    [No Abstract]   [Full Text] [Related]  

  • 9. How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
    Reid M; Abdool-Karim Q; Geng E; Goosby E
    PLoS Med; 2021 Mar; 18(3):e1003564. PubMed ID: 33705396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration projects in Vietnam and Uganda show global health security begins at the local level.
    Mitka M
    JAMA; 2014 Feb; 311(8):787-8. PubMed ID: 24570227
    [No Abstract]   [Full Text] [Related]  

  • 11. Community engagement; the master key to preventing Nigeria's obvious pandemic fatigue and the next COVID-19 wave.
    Ogundijo OA; Al-Mustapha AI; Abubakar AT; Imam AM; Bamidele F; Elelu N
    J Public Health Res; 2022 Jul; 11(3):22799036221107061. PubMed ID: 35911431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic.
    Ihekweazu C
    Emerg Infect Dis; 2022 Dec; 28(13):S299-S301. PubMed ID: 36502443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Mobile Positioning Data Contact Tracing and Patient Privacy Regulations: Exploratory Search of Global Response Strategies and the Use of Digital Tools in Nigeria.
    Ekong I; Chukwu E; Chukwu M
    JMIR Mhealth Uhealth; 2020 Apr; 8(4):e19139. PubMed ID: 32310817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operational Recommendations for Scarce Resource Allocation in a Public Health Crisis.
    Ehmann MR; Zink EK; Levin AB; Suarez JI; Belcher HME; Daugherty Biddison EL; Doberman DJ; D'Souza K; Fine DM; Garibaldi BT; Gehrie EA; Golden SH; Gurses AP; Hill PM; Hughes MT; Kahn JP; Koch CG; Marx JJ; Meisenberg BR; Natterman J; Rushton CH; Sapirstein A; Selinger SR; Stephens RS; Toner ES; Unguru Y; van Stone M; Kachalia A
    Chest; 2021 Mar; 159(3):1076-1083. PubMed ID: 32991873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A national survey of COVID-19 vaccine acceptance in Nigeria.
    Al-Mustapha AI; Okechukwu O; Olayinka A; Muhammed OR; Oyewo M; Owoicho SA; Abubakar AT; Olabisi A; Jibril A; Ereh S; Fakayode OE; Ogundijo OA; Elelu N; Adetunji VO
    Vaccine; 2022 Aug; 40(33):4726-4731. PubMed ID: 35764433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leading in a time of crisis: exploring early experiences of health facility leaders during the COVID-19 pandemic in Nigeria's epicentre.
    Balogun M; Dada FO; Oladimeji A; Gwacham-Anisiobi U; Sekoni A; Banke-Thomas A
    Leadersh Health Serv (Bradf Engl); 2022 May; ahead-of-print(ahead-of-print):. PubMed ID: 35543177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Government preparedness and response towards COVID-19 outbreak in Nigeria: A retrospective analysis of the last 6 months.
    Adesanya OA
    J Glob Health; 2020 Dec; 10(2):020382. PubMed ID: 33214891
    [No Abstract]   [Full Text] [Related]  

  • 19. New Zealand's COVID-19 elimination strategy.
    Baker MG; Kvalsvig A; Verrall AJ
    Med J Aust; 2020 Sep; 213(5):198-200.e1. PubMed ID: 32789868
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 gives the lie to global health expertise.
    Dalglish SL
    Lancet; 2020 Apr; 395(10231):1189. PubMed ID: 32222159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.